![Dawn Louro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Louro
Technik-/Wissenschafts-/F&E-Leiter bei
PALISADE BIO, INC.
Profil
Ms. Dawn Louro is a Head-Clinical Operations at Palisade Bio, Inc. Ms. Louro was previously employed as a Vice President-Clinical Operations by Landos Biopharma, Inc. and a Vice President-Clinical Operations by Statera Biopharma, Inc. She received her undergraduate degree from the University of Maryland.
Aktive Positionen von Dawn Louro
| Unternehmen | Position | Beginn |
|---|---|---|
| PALISADE BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Dawn Louro
| Unternehmen | Position | Ende |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.05.2024 |
| STATERA BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dawn Louro
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
